Free Trial

NOV (NOV) Financials

NOV logo
$21.18 +0.81 (+3.96%)
Closing price 03:59 PM Eastern
Extended Trading
$21.31 +0.13 (+0.63%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for NOV

Annual Income Statements for NOV

This table shows NOV's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-769 -2,412 -237 -31 -6,095 -2,542 -250 155 993 635 145
Consolidated Net Income / (Loss)
-767 -2,416 -236 -22 -6,093 -2,537 -245 155 985 635 151
Net Income / (Loss) Continuing Operations
-767 -2,416 1,548 -22 -6,093 -2,537 -245 155 985 635 151
Total Pre-Tax Income
-589 -2,623 -392 41 -6,462 -2,779 -230 238 612 831 375
Total Operating Income
-390 -2,411 -277 211 -6,279 -2,425 -134 264 651 876 494
Total Gross Profit
3,063 -101 1,784 1,444 845 434 774 1,334 1,833 2,010 1,767
Total Revenue
14,757 7,251 14,608 8,453 8,479 6,090 5,524 7,237 8,583 8,870 8,744
Operating Revenue
14,757 7,251 14,608 8,453 8,479 6,090 5,524 7,237 8,583 8,870 8,744
Total Cost of Revenue
11,694 7,352 12,824 7,009 7,634 5,656 4,750 5,903 6,750 6,860 6,977
Operating Cost of Revenue
11,694 7,352 12,824 7,009 7,634 5,656 4,750 5,903 6,750 6,860 6,977
Total Operating Expenses
3,453 2,310 277 1,233 7,124 2,859 908 1,070 1,182 1,134 1,273
Selling, General & Admin Expense
1,764 1,338 1,169 1,233 1,303 968 908 1,070 1,182 1,134 1,203
Impairment Charge
1,689 972 - 0.00 5,821 1,891 0.00 0.00 0.00 0.00 70
Total Other Income / (Expense), net
-199 -212 -115 -170 -183 -354 -96 -26 -39 -45 -119
Interest Expense
103 105 102 93 100 84 77 78 88 91 88
Interest & Investment Income
27 -6.00 20 22 7.00 -253 4.00 87 147 74 35
Other Income / (Expense), net
-123 -101 -33 -99 -90 -17 -23 -35 -98 -28 -66
Income Tax Expense
178 -207 -156 63 -369 -242 15 83 -373 196 224
Net Income / (Loss) Attributable to Noncontrolling Interest
2.00 -4.00 1.00 9.00 2.00 5.00 5.00 0.00 -8.00 0.00 6.00
Basic Earnings per Share
($1.99) ($6.41) ($0.63) ($0.08) ($15.96) ($6.62) ($0.65) $0.40 $2.53 $1.62 $0.39
Weighted Average Basic Shares Outstanding
387M 376M 377M 378M 382M 384M 386M 390M 393M 392M 372M
Diluted Earnings per Share
($1.99) ($6.41) ($0.63) ($0.08) ($15.96) ($6.62) ($0.65) $0.39 $2.50 $1.60 $0.39
Weighted Average Diluted Shares Outstanding
387M 376M 377M 378M 382M 384M 386M 394M 397M 396M 375M
Weighted Average Basic & Diluted Shares Outstanding
386.40M 376.30M 376.20M 387.50M 385.95M 388.21M 392.67M 392.83M 394.00M 380.82M 360.40M
Cash Dividends to Common per Share
$1.84 $0.61 $0.20 $0.20 $0.20 $0.05 $0.05 $0.20 $0.20 $0.28 $0.51

Quarterly Income Statements for NOV

This table shows NOV's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
114 598 119 226 130 160 73 108 42 -78 19
Consolidated Net Income / (Loss)
108 595 121 223 130 161 74 114 44 -81 20
Net Income / (Loss) Continuing Operations
108 595 121 223 130 161 74 114 44 -81 20
Total Pre-Tax Income
156 135 165 293 174 199 121 115 73 66 35
Total Operating Income
183 161 162 313 194 207 152 143 107 92 47
Total Gross Profit
468 497 458 590 469 493 447 446 412 462 379
Total Revenue
2,185 2,343 2,155 2,216 2,191 2,308 2,103 2,188 2,176 2,277 2,052
Operating Revenue
2,185 2,343 2,155 2,216 2,191 2,308 2,103 2,188 2,176 2,277 2,052
Total Cost of Revenue
1,717 1,846 1,697 1,626 1,722 1,815 1,656 1,742 1,764 1,815 1,673
Operating Cost of Revenue
1,717 1,846 1,697 1,626 1,722 1,815 1,656 1,742 1,764 1,815 1,673
Total Operating Expenses
285 336 296 277 275 286 295 303 305 370 332
Selling, General & Admin Expense
285 336 296 277 275 286 295 303 305 300 332
Total Other Income / (Expense), net
-27 -26 3.00 -20 -20 -8.00 -31 -28 -34 -26 -12
Interest Expense
23 23 24 22 21 24 22 22 22 22 22
Interest & Investment Income
21 25 37 16 11 10 11 11 0.00 13 8.00
Other Income / (Expense), net
-25 -28 -10 -14 -10 6.00 -20 -17 -12 -17 2.00
Income Tax Expense
48 -460 44 70 44 38 47 1.00 29 147 15
Net Income / (Loss) Attributable to Noncontrolling Interest
-6.00 -3.00 2.00 -3.00 0.00 1.00 1.00 6.00 2.00 -3.00 1.00
Basic Earnings per Share
$0.29 $1.53 $0.30 $0.57 $0.33 $0.42 $0.19 $0.29 $0.11 ($0.20) $0.05
Weighted Average Basic Shares Outstanding
393M 393M 394M 395M 392M 392M 381M 375M 370M 372M 361M
Diluted Earnings per Share
$0.29 $1.50 $0.30 $0.57 $0.33 $0.40 $0.19 $0.29 $0.11 ($0.20) $0.05
Weighted Average Diluted Shares Outstanding
396M 397M 397M 397M 395M 396M 383M 376M 371M 375M 364M
Weighted Average Basic & Diluted Shares Outstanding
393.93M 394.00M 395.54M 393.71M 389.08M 380.82M 375.74M 371.36M 364.75M 360.40M 358.89M
Cash Dividends to Common per Share
$0.05 $0.05 $0.05 $0.08 $0.08 $0.08 $0.08 $0.29 $0.08 $0.08 $0.09

Annual Cash Flow Statements for NOV

This table details how cash moves in and out of NOV's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-1,456 -672 -8.00 34 -256 521 -101 -522 -253 414 322
Net Cash From Operating Activities
1,332 960 832 521 714 926 291 -179 143 1,304 1,251
Net Cash From Continuing Operating Activities
1,332 960 832 521 714 926 291 -179 143 1,304 1,251
Net Income / (Loss) Continuing Operations
-767 -2,416 -236 -22 -6,093 -2,537 -245 155 985 635 151
Consolidated Net Income / (Loss)
-767 -2,416 -236 -22 -6,093 -2,537 -245 155 985 635 151
Depreciation Expense
747 703 698 690 533 352 306 301 302 343 355
Non-Cash Adjustments To Reconcile Net Income
2,076 2,107 433 87 6,561 2,603 329 -42 -44 182 224
Changes in Operating Assets and Liabilities, net
-724 566 -63 -234 -287 508 -99 -593 -1,100 144 521
Net Cash From Investing Activities
-514 -488 -245 -457 -315 -144 -196 -238 -293 -471 -362
Net Cash From Continuing Investing Activities
-514 -488 -245 -457 -315 -144 -196 -238 -293 -471 -362
Purchase of Property, Plant & Equipment
-453 -284 -192 -244 -233 -226 -201 -214 -283 -351 -375
Acquisitions
-86 -230 -86 -280 -180 -14 -52 -49 -22 -298 0.00
Divestitures
- - - - - - - 0.00 0.00 176 0.00
Other Investing Activities, net
25 26 33 67 98 96 57 25 12 2.00 13
Net Cash From Financing Activities
-2,163 -1,141 -595 -30 -647 -259 -189 -96 -103 -406 -584
Net Cash From Continuing Financing Activities
-2,163 -1,141 -595 -30 -647 -259 -189 -96 -103 -406 -584
Repayment of Debt
-10,615 -4,880 -513 0.00 -1,049 -245 -203 -14 -185 -461 -54
Repurchase of Common Equity
-2,221 - - - - - - 0.00 0.00 -229 -315
Payment of Dividends
-710 -230 -76 -76 -77 -19 -20 -78 -79 -108 -190
Issuance of Debt
11,377 3,972 - 54 511 36 60 20 184 420 3.00
Other Financing Activities, net
6.00 -3.00 -6.00 -8.00 -32 -31 -26 -24 -23 -28 -28
Effect of Exchange Rate Changes
-111 -3.00 - - - -2.00 -7.00 - 0.00 -13 17
Cash Interest Paid
103 101 97 90 85 83 76 75 85 86 85
Cash Income Taxes Paid
782 181 50 64 144 -9.00 -78 117 114 161 106

Quarterly Cash Flow Statements for NOV

This table details how cash moves in and out of NOV's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-79 303 -348 359 158 245 -73 -77 127 345 -210
Net Cash From Operating Activities
40 377 -78 432 359 591 135 191 352 573 -26
Net Cash From Continuing Operating Activities
40 377 -78 432 359 591 135 191 352 573 -26
Net Income / (Loss) Continuing Operations
108 595 121 223 130 161 74 114 44 -81 20
Consolidated Net Income / (Loss)
108 595 121 223 130 161 74 114 44 -81 20
Depreciation Expense
77 77 83 86 86 88 89 87 89 90 92
Non-Cash Adjustments To Reconcile Net Income
18 -30 -71 -1.00 109 145 -46 51 218 1.00 20
Changes in Operating Assets and Liabilities, net
-163 -265 -211 124 34 197 18 -61 1.00 563 -158
Net Cash From Investing Activities
-83 -82 -311 85 -82 -163 -81 -81 -104 -96 -64
Net Cash From Continuing Investing Activities
-83 -82 -311 85 -82 -163 -81 -81 -104 -96 -64
Purchase of Property, Plant & Equipment
-74 -76 -69 -82 -82 -118 -84 -83 -107 -101 -65
Other Investing Activities, net
5.00 2.00 1.00 - - 1.00 3.00 2.00 3.00 5.00 1.00
Net Cash From Financing Activities
-33 3.00 43 -156 -122 -171 -135 -198 -118 -133 -115
Net Cash From Continuing Financing Activities
-33 3.00 43 -156 -122 -171 -135 -198 -118 -133 -115
Repayment of Debt
-67 -94 -264 -418 -7.00 -22 -19 -15 -6.00 -14 -7.00
Repurchase of Common Equity
- - 0.00 - -80 -112 -81 -69 -80 -85 -67
Payment of Dividends
-20 -19 -20 -30 -29 -29 -28 -107 -28 -27 -33
Other Financing Activities, net
-6.00 -6.00 -6.00 -7.00 -6.00 -9.00 -7.00 -7.00 -6.00 -8.00 -8.00
Other Net Changes in Cash
- - - - - - - - - - -5.00
Cash Interest Paid
4.00 40 6.00 39 3.00 38 4.00 38 5.00 38 4.00
Cash Income Taxes Paid
31 31 28 49 47 37 15 71 93 -73 29

Annual Balance Sheets for NOV

This table presents NOV's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
25,970 21,140 20,206 19,796 13,149 9,929 9,550 10,135 11,294 11,361 11,291
Total Current Assets
11,425 7,876 7,217 7,279 6,113 5,209 4,902 5,493 5,840 5,770 5,820
Cash & Equivalents
2,080 1,408 1,437 1,427 1,171 1,692 1,591 1,069 816 1,230 1,552
Accounts Receivable
4,176 2,748 2,015 2,101 1,855 1,274 1,321 1,739 1,905 1,819 1,701
Inventories, net
4,678 3,325 3,003 2,986 2,197 1,408 1,331 1,813 2,151 1,932 1,799
Prepaid Expenses
491 395 267 200 247 224 198 187 229 212 172
Other Current Assets
- - 495 565 643 611 461 685 739 577 596
Plant, Property, & Equipment, net
3,124 3,150 3,002 2,797 2,354 1,927 1,823 1,781 1,865 1,922 2,050
Total Noncurrent Assets
11,421 10,114 9,987 9,720 4,682 2,793 2,825 2,861 3,589 3,669 3,421
Long-Term Investments
327 307 309 301 282 51 50 117 211 163 163
Noncurrent Note & Lease Receivables
- - - - 230 195 176 171 172 196 187
Goodwill
6,980 6,067 6,227 6,264 2,807 1,493 1,527 1,505 1,562 1,630 1,582
Intangible Assets
3,849 3,530 3,301 3,020 852 527 503 490 450 508 455
Noncurrent Deferred & Refundable Income Taxes
130 86 13 11 0.00 - - 0.00 488 413 358
Other Noncurrent Operating Assets
135 124 137 124 511 527 569 578 706 759 676
Total Liabilities & Shareholders' Equity
25,970 21,140 20,206 19,796 13,149 9,929 9,550 10,135 11,294 11,361 11,291
Total Liabilities
9,510 7,137 6,046 5,907 5,303 4,650 4,486 5,001 5,052 4,933 4,969
Total Current Liabilities
3,958 3,047 2,354 2,341 2,247 1,867 1,910 2,437 2,435 2,347 2,406
Short-Term Debt
2.00 506 6.00 - - 0.00 5.00 13 13 37 30
Accounts Payable
623 414 510 722 715 489 612 906 904 837 831
Accrued Expenses
2,284 1,568 1,238 1,088 949 863 778 959 870 861 822
Current Deferred Revenue
785 440 - - - - - 444 532 492 565
Current Deferred & Payable Income Tax Liabilities
264 119 81 66 42 51 24 28 22 18 57
Other Current Liabilities
- - 519 465 541 464 491 87 94 102 101
Total Noncurrent Liabilities
5,552 4,090 3,692 3,566 3,056 2,783 2,576 2,564 2,617 2,586 2,563
Long-Term Debt
3,907 2,708 2,706 2,482 1,989 1,834 1,708 1,717 1,712 1,703 1,688
Noncurrent Deferred & Payable Income Tax Liabilities
1,362 1,064 677 564 140 78 66 68 70 56 93
Other Noncurrent Operating Liabilities
283 318 309 520 927 871 802 779 835 827 782
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
16,460 14,003 14,160 13,889 7,846 5,279 5,064 5,134 6,242 6,428 6,322
Total Preferred & Common Equity
16,383 13,940 14,094 13,819 7,778 5,210 4,997 5,096 6,168 6,376 6,268
Total Common Equity
16,383 13,940 14,094 13,819 7,778 5,210 4,997 5,096 6,168 6,376 6,268
Common Stock
8,009 8,107 8,238 8,394 8,511 8,595 8,689 8,758 8,816 8,629 8,365
Retained Earnings
9,927 7,285 6,966 6,862 690 -1,876 -2,146 -2,069 -1,155 -628 -673
Accumulated Other Comprehensive Income / (Loss)
-1,553 -1,452 -1,110 -1,437 -1,423 -1,509 -1,546 -1,593 -1,493 -1,625 -1,424
Noncontrolling Interest
77 63 66 70 68 69 67 38 74 52 54

Quarterly Balance Sheets for NOV

This table presents NOV's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
9,761 10,177 10,446 10,498 11,305 11,297 11,422 11,273 11,363 11,338 11,143
Total Current Assets
5,179 5,422 5,610 5,658 5,688 5,844 5,918 5,784 5,781 5,762 5,721
Cash & Equivalents
998 774 592 513 468 827 985 1,157 1,080 1,207 1,342
Accounts Receivable
1,623 1,776 1,891 1,982 1,867 1,854 1,896 1,790 1,902 1,871 1,664
Inventories, net
1,755 2,036 2,199 2,277 2,278 2,157 2,123 1,942 1,929 1,886 1,874
Prepaid Expenses
212 199 224 211 261 234 230 215 215 222 207
Other Current Assets
591 637 704 675 814 772 684 680 655 576 634
Plant, Property, & Equipment, net
1,757 1,814 1,839 1,843 1,878 1,882 1,908 1,953 1,990 2,025 2,017
Total Noncurrent Assets
2,825 2,941 2,997 2,997 3,739 3,571 3,596 3,536 3,592 3,551 3,405
Long-Term Investments
82 144 184 198 247 168 170 157 178 173 165
Noncurrent Note & Lease Receivables
170 171 172 173 176 175 175 195 195 192 183
Goodwill
1,505 1,549 1,549 1,556 1,602 1,618 1,612 1,621 1,623 1,623 1,583
Intangible Assets
501 477 470 459 508 498 493 506 496 466 442
Noncurrent Deferred & Refundable Income Taxes
- - - - 484 396 407 388 415 389 347
Other Noncurrent Operating Assets
567 600 622 611 722 716 739 669 685 708 685
Total Liabilities & Shareholders' Equity
9,761 10,177 10,446 10,498 11,305 11,297 11,422 11,273 11,363 11,338 11,143
Total Liabilities
4,831 4,869 4,949 4,931 4,984 4,865 4,906 4,779 4,805 4,826 4,875
Total Current Liabilities
2,247 2,308 2,385 2,369 2,272 2,242 2,300 2,182 2,239 2,264 2,316
Short-Term Debt
10 13 13 13 44 24 28 38 38 34 27
Accounts Payable
774 961 1,007 925 823 809 835 796 823 798 852
Accrued Expenses
904 775 769 818 767 782 819 685 742 760 728
Current Deferred Revenue
- - - 488 533 508 495 520 513 564 575
Current Deferred & Payable Income Tax Liabilities
43 21 11 32 6.00 20 22 41 20 7.00 34
Other Current Liabilities
516 538 585 93 99 99 101 102 103 101 100
Total Noncurrent Liabilities
2,584 2,561 2,564 2,562 2,712 2,623 2,606 2,597 2,566 2,562 2,559
Long-Term Debt
1,720 1,719 1,715 1,716 1,764 1,724 1,721 1,699 1,690 1,692 1,688
Noncurrent Deferred & Payable Income Tax Liabilities
51 68 69 69 92 59 44 64 71 74 86
Other Noncurrent Operating Liabilities
813 774 780 777 856 840 841 834 805 796 785
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
4,930 5,308 5,497 5,567 6,321 6,432 6,516 6,494 6,558 6,512 6,268
Total Preferred & Common Equity
4,868 5,243 5,434 5,521 6,246 6,379 6,464 6,440 6,504 6,455 6,212
Total Common Equity
4,868 5,243 5,434 5,521 6,246 6,379 6,464 6,440 6,504 6,455 6,212
Common Stock
8,722 8,760 8,777 8,797 8,822 8,788 8,725 8,550 8,497 8,433 8,321
Retained Earnings
-2,154 -1,963 -1,828 -1,734 -1,056 -860 -759 -583 -582 -568 -687
Accumulated Other Comprehensive Income / (Loss)
-1,700 -1,554 -1,515 -1,542 -1,520 -1,549 -1,502 -1,527 -1,411 -1,410 -1,422
Noncontrolling Interest
62 65 63 46 75 53 52 54 54 57 56

Annual Metrics And Ratios for NOV

This table displays calculated financial ratios and metrics derived from NOV's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-31.17% -50.86% 101.46% -42.13% 0.31% -28.18% -9.29% 31.01% 18.60% 3.34% -1.42%
EBITDA Growth
-94.56% -873.08% 121.45% 106.70% -827.68% 64.19% 107.13% 255.70% 61.32% 39.30% -34.26%
EBIT Growth
-114.56% -389.67% 87.66% 136.13% -5,786.61% 61.66% 93.57% 245.86% 141.48% 53.35% -49.53%
NOPAT Growth
-110.75% -518.21% 88.51% 41.61% -3,782.10% 61.38% 94.47% 283.30% 509.41% -36.11% -70.28%
Net Income Growth
-130.59% -214.99% 90.23% 90.68% -27,595.45% 58.36% 90.34% 163.27% 535.48% -35.53% -76.22%
EPS Growth
-134.19% -222.11% 90.17% 87.30% -19,850.00% 58.52% 90.18% 160.00% 541.03% -36.00% -75.63%
Operating Cash Flow Growth
-49.04% -27.93% -13.33% -37.38% 37.04% 29.69% -68.57% -161.51% 179.89% 811.89% -4.06%
Free Cash Flow Firm Growth
-56.53% -57.21% -76.42% 103.06% 404.54% -29.54% -89.33% -363.96% 42.11% 489.48% -22.23%
Invested Capital Growth
-10.37% -13.70% -2.43% -3.19% -42.76% -35.93% -4.36% 10.55% 22.23% -2.38% -6.64%
Revenue Q/Q Growth
-16.83% -12.44% 107.88% -44.85% -1.36% -13.54% 3.56% 8.32% 3.25% -0.39% -0.35%
EBITDA Q/Q Growth
-91.44% 32.17% 235.19% 25.31% -10.03% 3.95% 214.62% 33.50% 1.79% 8.27% -14.80%
EBIT Q/Q Growth
-126.03% 25.66% 68.50% 307.41% -7.80% 4.08% 64.56% 136.08% 2.60% 10.42% -24.38%
NOPAT Q/Q Growth
-117.94% 26.43% 70.28% -1,344.17% -7.46% 1.94% 68.10% 933.72% 103.09% -42.13% -57.78%
Net Income Q/Q Growth
-156.73% 24.99% 74.84% 57.69% -7.03% 1.44% 55.45% 1,092.31% 101.43% -40.60% -61.58%
EPS Q/Q Growth
-160.30% 23.87% 74.60% 50.00% -7.04% 1.63% 55.17% 1,200.00% 98.41% -40.74% -60.61%
Operating Cash Flow Q/Q Growth
-8.39% -32.44% 25.30% -16.10% 54.55% -23.66% -34.01% 39.73% 278.75% 19.63% -1.42%
Free Cash Flow Firm Q/Q Growth
-1.23% -46.18% -38.81% 48.45% -6.43% -9.84% -69.65% 25.89% 56.20% 32.06% -10.26%
Invested Capital Q/Q Growth
-10.24% -4.80% -1.35% -2.98% -6.96% -7.73% 1.42% 1.76% 5.39% -4.71% -7.77%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
20.76% -1.39% 12.21% 17.08% 9.97% 7.13% 14.01% 18.43% 21.36% 22.66% 20.21%
EBITDA Margin
1.59% -24.95% 2.66% 9.49% -68.83% -34.32% 2.70% 7.32% 9.96% 13.43% 8.95%
Operating Margin
-2.64% -33.25% -1.90% 2.50% -74.05% -39.82% -2.43% 3.65% 7.58% 9.88% 5.65%
EBIT Margin
-3.48% -34.64% -2.12% 1.33% -75.12% -40.10% -2.84% 3.16% 6.44% 9.56% 4.89%
Profit (Net Income) Margin
-5.20% -33.32% -1.62% -0.26% -71.86% -41.66% -4.44% 2.14% 11.48% 7.16% 1.73%
Tax Burden Percent
130.22% 92.11% 60.20% -53.66% 94.29% 91.29% 106.52% 65.13% 160.95% 76.41% 40.27%
Interest Burden Percent
114.81% 104.42% 126.45% 36.61% 101.46% 113.80% 146.50% 103.93% 110.67% 98.00% 87.62%
Effective Tax Rate
0.00% 0.00% 0.00% 153.66% 0.00% 0.00% 0.00% 34.87% -60.95% 23.59% 59.73%
Return on Invested Capital (ROIC)
-1.44% -10.09% -1.27% -0.76% -38.18% -24.69% -1.79% 3.18% 16.61% 9.76% 3.04%
ROIC Less NNEP Spread (ROIC-NNEP)
-129.75% -58.62% -4.68% 9.85% -301.39% -292.47% -187.31% -2.32% 6.50% 3.18% -24.34%
Return on Net Nonoperating Assets (RNNOA)
-2.68% -5.78% -0.41% 0.60% -17.89% -13.97% -2.95% -0.14% 0.71% 0.26% -0.67%
Return on Equity (ROE)
-4.12% -15.86% -1.68% -0.16% -56.07% -38.66% -4.74% 3.04% 17.32% 10.02% 2.37%
Cash Return on Invested Capital (CROIC)
9.50% 4.62% 1.19% 2.48% 16.21% 19.12% 2.67% -6.84% -3.40% 12.17% 9.91%
Operating Return on Assets (OROA)
-1.72% -10.66% -1.50% 0.56% -38.66% -21.16% -1.61% 2.33% 5.16% 7.49% 3.78%
Return on Assets (ROA)
-2.58% -10.26% -1.14% -0.11% -36.99% -21.99% -2.52% 1.57% 9.19% 5.61% 1.33%
Return on Common Equity (ROCE)
-4.10% -15.79% -1.67% -0.16% -55.71% -38.26% -4.68% 3.01% 17.15% 9.92% 2.35%
Return on Equity Simple (ROE_SIMPLE)
-4.68% -17.33% -1.67% -0.16% -78.34% -48.69% -4.90% 3.04% 15.97% 9.96% 0.00%
Net Operating Profit after Tax (NOPAT)
-273 -1,688 -194 -113 -4,395 -1,698 -94 172 1,048 669 199
NOPAT Margin
-1.85% -23.28% -1.33% -1.34% -51.84% -27.87% -1.70% 2.38% 12.21% 7.55% 2.27%
Net Nonoperating Expense Percent (NNEP)
128.31% 48.54% 3.42% -10.61% 263.21% 267.78% 185.52% 5.50% 10.11% 6.58% 27.38%
Return On Investment Capital (ROIC_SIMPLE)
-1.34% -9.80% -1.15% -0.69% -44.69% -23.86% -1.38% 2.50% 13.15% 8.20% 2.47%
Cost of Revenue to Revenue
79.24% 101.39% 87.79% 82.92% 90.03% 92.87% 85.99% 81.57% 78.64% 77.34% 79.79%
SG&A Expenses to Revenue
11.95% 18.45% 8.00% 14.59% 15.37% 15.89% 16.44% 14.79% 13.77% 12.78% 13.76%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
23.40% 31.86% 1.90% 14.59% 84.02% 46.95% 16.44% 14.79% 13.77% 12.78% 14.56%
Earnings before Interest and Taxes (EBIT)
-513 -2,512 -310 112 -6,369 -2,442 -157 229 553 848 428
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
234 -1,809 388 802 -5,836 -2,090 149 530 855 1,191 783
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.70 0.94 0.91 0.67 1.18 0.98 1.01 1.56 1.27 0.89 0.91
Price to Tangible Book Value (P/TBV)
2.07 3.03 2.81 2.04 2.23 1.59 1.71 2.56 1.88 1.33 1.35
Price to Revenue (P/Rev)
0.78 1.82 0.88 1.10 1.08 0.83 0.92 1.10 0.91 0.64 0.65
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 51.22 7.87 8.90 39.32
Dividend Yield
6.02% 1.75% 0.59% 0.83% 0.84% 1.53% 0.39% 0.99% 1.01% 1.89% 3.26%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.95% 12.70% 11.24% 2.54%
Enterprise Value to Invested Capital (EV/IC)
0.73 0.95 0.92 0.69 1.17 0.98 1.01 1.50 1.24 0.89 0.91
Enterprise Value to Revenue (EV/Rev)
0.89 2.03 0.95 1.19 1.15 0.86 0.94 1.18 1.00 0.68 0.66
Enterprise Value to EBITDA (EV/EBITDA)
55.86 0.00 35.69 12.59 0.00 0.00 34.97 16.08 10.04 5.08 7.35
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 90.15 0.00 0.00 0.00 37.21 15.53 7.13 13.45
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 49.56 8.20 9.04 28.95
Enterprise Value to Operating Cash Flow (EV/OCF)
9.81 15.34 16.64 19.38 13.70 5.66 17.90 0.00 60.06 4.64 4.60
Enterprise Value to Free Cash Flow (EV/FCFF)
7.24 19.07 76.05 27.30 5.24 3.99 37.16 0.00 0.00 7.25 8.87
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.24 0.23 0.19 0.18 0.25 0.35 0.34 0.34 0.28 0.27 0.27
Long-Term Debt to Equity
0.24 0.19 0.19 0.18 0.25 0.35 0.34 0.33 0.27 0.26 0.27
Financial Leverage
0.02 0.10 0.09 0.06 0.06 0.05 0.02 0.06 0.11 0.08 0.03
Leverage Ratio
1.60 1.55 1.47 1.43 1.52 1.76 1.88 1.93 1.88 1.79 1.78
Compound Leverage Factor
1.84 1.61 1.86 0.52 1.54 2.00 2.76 2.01 2.08 1.75 1.56
Debt to Total Capital
19.19% 18.67% 16.07% 15.16% 20.22% 25.78% 25.28% 25.20% 21.65% 21.30% 21.37%
Short-Term Debt to Total Capital
0.01% 2.94% 0.04% 0.00% 0.00% 0.00% 0.07% 0.19% 0.16% 0.45% 0.37%
Long-Term Debt to Total Capital
19.18% 15.73% 16.04% 15.16% 20.22% 25.78% 25.20% 25.01% 21.49% 20.85% 21.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.38% 0.37% 0.39% 0.43% 0.69% 0.97% 0.99% 0.55% 0.93% 0.64% 0.67%
Common Equity to Total Capital
80.43% 80.97% 83.53% 84.41% 79.08% 73.25% 73.73% 74.24% 77.42% 78.06% 77.96%
Debt to EBITDA
16.71 -1.78 6.99 3.09 -0.34 -0.88 11.50 3.26 2.02 1.46 2.19
Net Debt to EBITDA
6.42 -0.83 2.49 0.94 -0.09 -0.04 0.48 1.03 0.82 0.29 0.00
Long-Term Debt to EBITDA
16.70 -1.50 6.97 3.09 -0.34 -0.88 11.46 3.24 2.00 1.43 2.16
Debt to NOPAT
-14.32 -1.90 -13.99 -21.92 -0.45 -1.08 -18.26 10.06 1.65 2.60 8.64
Net Debt to NOPAT
-5.50 -0.89 -4.98 -6.66 -0.12 -0.05 -0.77 3.16 0.67 0.52 0.02
Long-Term Debt to NOPAT
-14.31 -1.60 -13.96 -21.92 -0.45 -1.08 -18.21 9.99 1.63 2.54 8.49
Altman Z-Score
2.11 1.81 2.72 2.17 0.51 0.60 1.26 1.82 2.07 2.00 1.87
Noncontrolling Interest Sharing Ratio
0.42% 0.46% 0.46% 0.48% 0.63% 1.04% 1.31% 1.03% 0.98% 0.99% 0.83%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.89 2.58 3.07 3.11 2.72 2.79 2.57 2.25 2.40 2.46 2.42
Quick Ratio
1.58 1.36 1.47 1.51 1.35 1.59 1.52 1.15 1.12 1.30 1.35
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,805 772 182 370 1,866 1,315 140 -370 -214 834 649
Operating Cash Flow to CapEx
294.04% 338.03% 433.33% 213.52% 306.44% 409.73% 144.78% -83.64% 50.53% 371.51% 333.60%
Free Cash Flow to Firm to Interest Expense
17.52 7.36 1.79 3.98 18.66 15.65 1.82 -4.74 -2.43 9.17 7.37
Operating Cash Flow to Interest Expense
12.93 9.14 8.16 5.60 7.14 11.02 3.78 -2.29 1.63 14.33 14.22
Operating Cash Flow Less CapEx to Interest Expense
8.53 6.44 6.27 2.98 4.81 8.33 1.17 -5.04 -1.59 10.47 9.95
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.50 0.31 0.71 0.42 0.51 0.53 0.57 0.74 0.80 0.78 0.77
Accounts Receivable Turnover
2.82 2.09 6.13 4.11 4.29 3.89 4.26 4.73 4.71 4.76 4.97
Inventory Turnover
2.35 1.84 4.05 2.34 2.95 3.14 3.47 3.76 3.41 3.36 3.74
Fixed Asset Turnover
4.55 2.31 4.75 2.92 3.29 2.85 2.95 4.02 4.71 4.68 4.40
Accounts Payable Turnover
12.91 14.18 27.76 11.38 10.62 9.40 8.63 7.78 7.46 7.88 8.37
Days Sales Outstanding (DSO)
129.48 174.27 59.50 88.86 85.15 93.77 85.73 77.17 77.48 76.62 73.47
Days Inventory Outstanding (DIO)
155.42 198.66 90.05 155.94 123.91 116.32 105.24 97.20 107.17 108.62 97.59
Days Payable Outstanding (DPO)
28.28 25.74 13.15 32.08 34.35 38.85 42.30 46.93 48.94 46.32 43.63
Cash Conversion Cycle (CCC)
256.63 347.19 136.41 212.73 174.70 171.24 148.67 127.44 135.72 138.93 127.43
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
17,962 15,502 15,126 14,643 8,382 5,370 5,136 5,678 6,940 6,775 6,325
Invested Capital Turnover
0.78 0.43 0.95 0.57 0.74 0.89 1.05 1.34 1.36 1.29 1.34
Increase / (Decrease) in Invested Capital
-2,078 -2,460 -376 -483 -6,261 -3,012 -234 542 1,262 -165 -450
Enterprise Value (EV)
13,071 14,725 13,848 10,097 9,778 5,245 5,210 8,521 8,588 6,049 5,758
Market Capitalization
11,492 13,163 12,816 9,273 9,174 5,085 5,071 7,939 7,816 5,650 5,701
Book Value per Share
$43.60 $36.91 $37.09 $36.05 $20.16 $13.42 $12.79 $12.97 $15.66 $16.39 $17.18
Tangible Book Value per Share
$14.78 $11.50 $12.01 $11.83 $10.68 $8.22 $7.59 $7.89 $10.55 $10.89 $11.60
Total Capital
20,369 17,217 16,872 16,371 9,835 7,113 6,777 6,864 7,967 8,168 8,040
Total Debt
3,909 3,214 2,712 2,482 1,989 1,834 1,713 1,730 1,725 1,740 1,718
Total Long-Term Debt
3,907 2,708 2,706 2,482 1,989 1,834 1,708 1,717 1,712 1,703 1,688
Net Debt
1,502 1,499 966 754 536 91 72 544 698 347 3.00
Capital Expenditures (CapEx)
453 284 192 244 233 226 201 214 283 351 375
Debt-free, Cash-free Net Working Capital (DFCFNWC)
5,389 3,927 3,432 3,511 2,695 1,650 1,406 2,000 2,602 2,230 1,892
Debt-free Net Working Capital (DFNWC)
7,469 5,335 4,869 4,938 3,866 3,342 2,997 3,069 3,418 3,460 3,444
Net Working Capital (NWC)
7,467 4,829 4,863 4,938 3,866 3,342 2,992 3,056 3,405 3,423 3,414
Net Nonoperating Expense (NNE)
494 728 42 -91 1,698 840 151 17 63 34 48
Net Nonoperating Obligations (NNO)
1,502 1,499 966 754 536 91 72 544 698 347 3.00
Total Depreciation and Amortization (D&A)
747 703 698 690 533 352 306 301 302 343 355
Debt-free, Cash-free Net Working Capital to Revenue
36.52% 54.16% 23.49% 41.54% 31.78% 27.09% 25.45% 27.64% 30.32% 25.14% 21.64%
Debt-free Net Working Capital to Revenue
50.61% 73.58% 33.33% 58.42% 45.60% 54.88% 54.25% 42.41% 39.82% 39.01% 39.39%
Net Working Capital to Revenue
50.60% 66.60% 33.29% 58.42% 45.60% 54.88% 54.16% 42.23% 39.67% 38.59% 39.04%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($1.99) ($6.41) ($0.63) ($0.08) ($15.96) ($6.62) ($0.65) $0.40 $2.53 $1.62 $0.39
Adjusted Weighted Average Basic Shares Outstanding
387M 376M 377M 378M 382M 384M 386M 390M 393M 392M 372M
Adjusted Diluted Earnings per Share
($1.99) ($6.41) ($0.63) ($0.08) ($15.96) ($6.62) ($0.65) $0.39 $2.50 $1.60 $0.39
Adjusted Weighted Average Diluted Shares Outstanding
387M 376M 377M 378M 382M 384M 386M 394M 397M 396M 375M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
375.80M 378.73M 380.14M 383.43M 385.95M 388.21M 392.67M 392.83M 394.00M 380.82M 360.40M
Normalized Net Operating Profit after Tax (NOPAT)
909 -1,007 -194 148 -321 -374 -94 172 456 669 395
Normalized NOPAT Margin
6.16% -13.89% -1.33% 1.75% -3.78% -6.14% -1.70% 2.38% 5.31% 7.55% 4.52%
Pre Tax Income Margin
-3.99% -36.17% -2.68% 0.49% -76.21% -45.63% -4.16% 3.29% 7.13% 9.37% 4.29%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-4.98 -23.92 -3.04 1.20 -63.69 -29.07 -2.04 2.94 6.28 9.32 4.86
NOPAT to Interest Expense
-2.65 -16.07 -1.90 -1.22 -43.95 -20.21 -1.22 2.20 11.91 7.36 2.26
EBIT Less CapEx to Interest Expense
-9.38 -26.63 -4.92 -1.42 -66.02 -31.76 -4.65 0.19 3.07 5.46 0.60
NOPAT Less CapEx to Interest Expense
-7.05 -18.78 -3.78 -3.84 -46.28 -22.90 -3.83 -0.54 8.69 3.50 -2.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-92.57% -9.52% -32.20% -345.45% -1.26% -0.75% -8.16% 50.32% 8.02% 17.01% 125.83%
Augmented Payout Ratio
-382.14% -9.52% -32.20% -345.45% -1.26% -0.75% -8.16% 50.32% 8.02% 53.07% 334.44%

Quarterly Metrics And Ratios for NOV

This table displays calculated financial ratios and metrics derived from NOV's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 360,404,544.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 360,404,544.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.05
Growth Metrics
- - - - - - - - - - -
Revenue Growth
15.67% 13.02% 9.84% 5.88% 0.27% -1.49% -2.41% -1.26% -0.68% -1.34% -2.43%
EBITDA Growth
66.67% 7.69% 25.67% 72.65% 14.89% 43.33% -5.96% -44.68% -31.85% -45.18% -36.20%
EBIT Growth
143.08% 11.76% 38.18% 96.71% 16.46% 60.15% -13.16% -57.86% -48.37% -64.79% -62.88%
NOPAT Growth
321.21% 523.85% 9.37% 47.54% 14.41% -76.40% -21.75% -40.49% -55.50% -167.42% -71.11%
Net Income Growth
208.57% 501.01% -3.20% 42.04% 20.37% -72.94% -38.84% -48.88% -66.15% -150.31% -72.97%
EPS Growth
262.50% 476.92% -6.25% 46.15% 13.79% -73.33% -36.67% -49.12% -66.67% -150.00% -73.68%
Operating Cash Flow Growth
137.74% 144.81% 61.39% 700.00% 797.50% 56.76% 273.08% -55.79% -1.95% -3.05% -119.26%
Free Cash Flow Firm Growth
-80.75% -28.99% -54.90% 43.53% 56.73% 160.19% 150.29% 160.02% 183.28% 1.39% -20.70%
Invested Capital Growth
18.01% 22.23% 21.10% 11.41% 7.97% -2.38% -6.70% -2.19% -3.54% -6.64% -6.38%
Revenue Q/Q Growth
4.40% 7.23% -8.02% 2.83% -1.13% 5.34% -8.88% 4.04% -0.55% 4.64% -9.88%
EBITDA Q/Q Growth
5.38% -10.64% 11.90% 63.83% -29.87% 11.48% -26.58% -3.62% -13.62% -10.33% -14.55%
EBIT Q/Q Growth
3.95% -15.82% 14.29% 96.71% -38.46% 15.76% -38.03% -4.55% -24.60% -21.05% -34.67%
NOPAT Q/Q Growth
-21.53% 460.09% -83.26% 100.52% -39.16% 15.54% -44.49% 52.49% -54.50% -275.07% 123.79%
Net Income Q/Q Growth
-31.21% 450.93% -79.66% 84.30% -41.70% 23.85% -54.04% 54.05% -61.40% -284.09% 124.69%
EPS Q/Q Growth
-25.64% 417.24% -80.00% 90.00% -42.11% 21.21% -52.50% 52.63% -62.07% -281.82% 125.00%
Operating Cash Flow Q/Q Growth
155.56% 842.50% -120.69% 653.85% -16.90% 64.62% -77.16% 41.48% 84.29% 62.78% -104.54%
Free Cash Flow Firm Q/Q Growth
0.37% 37.11% -112.38% 57.57% 23.65% 187.48% 77.45% -49.36% 5.94% 6.51% 38.79%
Invested Capital Q/Q Growth
2.11% 5.39% 6.83% -3.09% -1.04% -4.71% 2.10% 1.60% -2.42% -7.77% 2.39%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
21.42% 21.21% 21.25% 26.62% 21.41% 21.36% 21.26% 20.38% 18.93% 20.29% 18.47%
EBITDA Margin
10.76% 8.96% 10.90% 17.37% 12.32% 13.04% 10.51% 9.73% 8.46% 7.25% 6.87%
Operating Margin
8.38% 6.87% 7.52% 14.12% 8.85% 8.97% 7.23% 6.54% 4.92% 4.04% 2.29%
EBIT Margin
7.23% 5.68% 7.05% 13.49% 8.40% 9.23% 6.28% 5.76% 4.37% 3.29% 2.39%
Profit (Net Income) Margin
4.94% 25.39% 5.61% 10.06% 5.93% 6.98% 3.52% 5.21% 2.02% -3.56% 0.97%
Tax Burden Percent
69.23% 440.74% 73.33% 76.11% 74.71% 80.90% 61.16% 99.13% 60.27% -122.73% 57.14%
Interest Burden Percent
98.73% 101.50% 108.55% 97.99% 94.57% 93.43% 91.67% 91.27% 76.84% 88.00% 71.43%
Effective Tax Rate
30.77% -340.74% 26.67% 23.89% 25.29% 19.10% 38.84% 0.87% 39.73% 222.73% 42.86%
Return on Invested Capital (ROIC)
7.92% 41.20% 7.15% 14.03% 8.60% 9.39% 5.44% 8.01% 3.72% -6.62% 1.70%
ROIC Less NNEP Spread (ROIC-NNEP)
5.68% 22.75% 7.38% 12.25% 6.75% 8.15% 2.94% 3.47% -0.64% 11.61% -0.47%
Return on Net Nonoperating Assets (RNNOA)
0.90% 2.48% 1.21% 1.75% 0.90% 0.67% 0.35% 0.33% -0.05% 0.32% -0.02%
Return on Equity (ROE)
8.83% 43.69% 8.36% 15.78% 9.50% 10.06% 5.79% 8.34% 3.68% -6.30% 1.68%
Cash Return on Invested Capital (CROIC)
-8.04% -3.40% -3.33% 6.00% 9.23% 12.17% 15.97% 9.91% 10.35% 9.91% 8.54%
Operating Return on Assets (OROA)
5.93% 4.55% 5.76% 11.04% 6.82% 7.23% 4.90% 4.47% 3.37% 2.54% 1.85%
Return on Assets (ROA)
4.06% 20.34% 4.59% 8.24% 4.82% 5.46% 2.75% 4.04% 1.56% -2.75% 0.76%
Return on Common Equity (ROCE)
8.74% 43.26% 8.26% 15.63% 9.43% 9.96% 5.73% 8.27% 3.65% -6.25% 1.66%
Return on Equity Simple (ROE_SIMPLE)
8.86% 0.00% 15.71% 16.41% 16.54% 0.00% 9.13% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
127 710 119 238 145 167 93 142 64 -113 27
NOPAT Margin
5.80% 30.29% 5.51% 10.75% 6.62% 7.26% 4.42% 6.48% 2.96% -4.96% 1.31%
Net Nonoperating Expense Percent (NNEP)
2.24% 18.45% -0.23% 1.79% 1.85% 1.24% 2.50% 4.54% 4.36% -18.23% 2.17%
Return On Investment Capital (ROIC_SIMPLE)
1.74% 8.91% 1.46% 2.91% 1.75% 2.05% 1.13% 1.71% 0.78% -1.40% 0.34%
Cost of Revenue to Revenue
78.58% 78.79% 78.75% 73.38% 78.59% 78.64% 78.74% 79.62% 81.07% 79.71% 81.53%
SG&A Expenses to Revenue
13.04% 14.34% 13.74% 12.50% 12.55% 12.39% 14.03% 13.85% 14.02% 13.18% 16.18%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
13.04% 14.34% 13.74% 12.50% 12.55% 12.39% 14.03% 13.85% 14.02% 16.25% 16.18%
Earnings before Interest and Taxes (EBIT)
158 133 152 299 184 213 132 126 95 75 49
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
235 210 235 385 270 301 221 213 184 165 141
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.45 1.27 1.21 1.16 0.96 0.89 0.90 0.71 0.76 0.91 1.09
Price to Tangible Book Value (P/TBV)
2.29 1.88 1.82 1.74 1.43 1.33 1.34 1.06 1.13 1.35 1.62
Price to Revenue (P/Rev)
0.97 0.91 0.86 0.83 0.70 0.64 0.66 0.53 0.56 0.65 0.78
Price to Earnings (P/E)
16.09 7.87 7.65 7.01 5.80 8.90 9.84 9.86 12.85 39.32 74.50
Dividend Yield
0.98% 1.01% 1.04% 1.20% 1.58% 1.89% 1.97% 4.13% 3.85% 3.26% 2.79%
Earnings Yield
6.21% 12.70% 13.07% 14.27% 17.24% 11.24% 10.16% 10.14% 7.78% 2.54% 1.34%
Enterprise Value to Invested Capital (EV/IC)
1.38 1.24 1.18 1.14 0.97 0.89 0.91 0.74 0.78 0.91 1.09
Enterprise Value to Revenue (EV/Rev)
1.09 1.00 0.99 0.92 0.77 0.68 0.71 0.59 0.61 0.66 0.81
Enterprise Value to EBITDA (EV/EBITDA)
10.83 10.04 9.65 7.71 6.25 5.08 5.33 5.14 5.79 7.35 10.02
Enterprise Value to EBIT (EV/EBIT)
16.87 15.53 14.64 11.07 8.95 7.13 7.58 7.89 9.41 13.45 20.42
Enterprise Value to NOPAT (EV/NOPAT)
17.63 8.20 8.17 7.17 5.94 9.04 9.70 9.44 11.30 28.95 53.94
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 60.06 32.63 10.65 6.30 4.64 4.14 4.05 4.20 4.60 6.46
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 20.09 10.87 7.25 5.48 7.34 7.36 8.87 12.32
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.31 0.28 0.29 0.27 0.27 0.27 0.27 0.26 0.27 0.27 0.27
Long-Term Debt to Equity
0.31 0.27 0.28 0.27 0.26 0.26 0.26 0.26 0.26 0.27 0.27
Financial Leverage
0.16 0.11 0.16 0.14 0.13 0.08 0.12 0.09 0.07 0.03 0.05
Leverage Ratio
1.93 1.88 1.85 1.82 1.81 1.79 1.76 1.74 1.75 1.78 1.76
Compound Leverage Factor
1.91 1.91 2.01 1.79 1.72 1.67 1.62 1.59 1.34 1.56 1.25
Debt to Total Capital
23.70% 21.65% 22.24% 21.37% 21.16% 21.30% 21.10% 20.85% 20.95% 21.37% 21.48%
Short-Term Debt to Total Capital
0.18% 0.16% 0.54% 0.29% 0.34% 0.45% 0.46% 0.46% 0.41% 0.37% 0.34%
Long-Term Debt to Total Capital
23.52% 21.49% 21.70% 21.08% 20.82% 20.85% 20.64% 20.40% 20.54% 21.00% 21.14%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.63% 0.93% 0.92% 0.65% 0.63% 0.64% 0.66% 0.65% 0.69% 0.67% 0.70%
Common Equity to Total Capital
75.67% 77.42% 76.84% 77.98% 78.21% 78.06% 78.24% 78.49% 78.36% 77.96% 77.82%
Debt to EBITDA
2.06 2.02 2.00 1.64 1.59 1.46 1.48 1.72 1.88 2.19 2.44
Net Debt to EBITDA
1.21 0.82 1.21 0.71 0.54 0.29 0.36 0.47 0.38 0.00 0.30
Long-Term Debt to EBITDA
2.04 2.00 1.95 1.62 1.56 1.43 1.44 1.68 1.84 2.16 2.40
Debt to NOPAT
3.35 1.65 1.70 1.53 1.51 2.60 2.68 3.16 3.66 8.64 13.14
Net Debt to NOPAT
1.97 0.67 1.03 0.66 0.51 0.52 0.65 0.86 0.73 0.02 1.59
Long-Term Debt to NOPAT
3.33 1.63 1.65 1.51 1.49 2.54 2.63 3.09 3.59 8.49 12.93
Altman Z-Score
1.96 1.95 1.96 2.06 1.88 1.81 1.86 1.69 1.71 1.76 1.91
Noncontrolling Interest Sharing Ratio
1.03% 0.98% 1.20% 0.97% 0.81% 0.99% 1.01% 0.82% 0.84% 0.83% 0.86%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.39 2.40 2.50 2.61 2.57 2.46 2.65 2.58 2.55 2.42 2.47
Quick Ratio
1.05 1.12 1.03 1.20 1.25 1.30 1.35 1.33 1.36 1.35 1.30
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-878 -552 -1,173 -498 -380 332 590 299 316 337 468
Operating Cash Flow to CapEx
54.05% 496.05% -113.04% 526.83% 437.80% 500.85% 160.71% 230.12% 328.97% 567.33% -40.00%
Free Cash Flow to Firm to Interest Expense
-38.19 -24.02 -48.88 -22.63 -18.10 13.85 26.82 13.58 14.39 15.32 21.27
Operating Cash Flow to Interest Expense
1.74 16.39 -3.25 19.64 17.10 24.63 6.14 8.68 16.00 26.05 -1.18
Operating Cash Flow Less CapEx to Interest Expense
-1.48 13.09 -6.13 15.91 13.19 19.71 2.32 4.91 11.14 21.45 -4.14
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.82 0.80 0.82 0.82 0.81 0.78 0.78 0.78 0.77 0.77 0.78
Accounts Receivable Turnover
4.61 4.71 4.82 4.75 4.59 4.76 4.82 4.68 4.66 4.97 5.03
Inventory Turnover
3.24 3.41 3.20 3.16 3.13 3.36 3.23 3.39 3.48 3.74 3.67
Fixed Asset Turnover
4.62 4.71 4.75 4.78 4.75 4.68 4.60 4.54 4.46 4.40 4.38
Accounts Payable Turnover
7.69 7.46 7.73 7.58 7.83 7.88 8.42 8.50 8.55 8.37 8.49
Days Sales Outstanding (DSO)
79.14 77.48 75.76 76.80 79.48 76.62 75.69 77.98 78.35 73.47 72.51
Days Inventory Outstanding (DIO)
112.62 107.17 114.17 115.45 116.53 108.62 112.94 107.53 104.86 97.59 99.57
Days Payable Outstanding (DPO)
47.45 48.94 47.21 48.13 46.61 46.32 43.33 42.95 42.72 43.63 43.00
Cash Conversion Cycle (CCC)
144.31 135.72 142.71 144.12 149.39 138.93 145.30 142.56 140.49 127.43 129.08
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
6,585 6,940 7,414 7,185 7,110 6,775 6,917 7,028 6,858 6,325 6,476
Invested Capital Turnover
1.37 1.36 1.30 1.31 1.30 1.29 1.23 1.24 1.26 1.34 1.30
Increase / (Decrease) in Invested Capital
1,005 1,262 1,292 736 525 -165 -497 -157 -252 -450 -441
Enterprise Value (EV)
9,094 8,588 8,712 8,214 6,870 6,049 6,273 5,168 5,324 5,758 7,043
Market Capitalization
8,030 7,816 7,544 7,408 6,224 5,650 5,796 4,644 4,921 5,701 6,779
Book Value per Share
$14.02 $15.66 $15.85 $16.13 $16.42 $16.39 $16.91 $17.31 $17.38 $17.18 $17.24
Tangible Book Value per Share
$8.90 $10.55 $10.50 $10.78 $11.07 $10.89 $11.33 $11.67 $11.76 $11.60 $11.62
Total Capital
7,296 7,967 8,129 8,180 8,265 8,168 8,231 8,286 8,238 8,040 7,983
Total Debt
1,729 1,725 1,808 1,748 1,749 1,740 1,737 1,728 1,726 1,718 1,715
Total Long-Term Debt
1,716 1,712 1,764 1,724 1,721 1,703 1,699 1,690 1,692 1,688 1,688
Net Debt
1,018 698 1,093 753 594 347 423 470 346 3.00 208
Capital Expenditures (CapEx)
74 76 69 82 82 118 84 83 107 101 65
Debt-free, Cash-free Net Working Capital (DFCFNWC)
2,789 2,602 2,992 2,799 2,661 2,230 2,483 2,500 2,325 1,892 2,090
Debt-free Net Working Capital (DFNWC)
3,302 3,418 3,460 3,626 3,646 3,460 3,640 3,580 3,532 3,444 3,432
Net Working Capital (NWC)
3,289 3,405 3,416 3,602 3,618 3,423 3,602 3,542 3,498 3,414 3,405
Net Nonoperating Expense (NNE)
19 115 -2.20 15 15 6.47 19 28 20 -32 6.86
Net Nonoperating Obligations (NNO)
1,018 698 1,093 753 594 347 423 470 346 3.00 208
Total Depreciation and Amortization (D&A)
77 77 83 86 86 88 89 87 89 90 92
Debt-free, Cash-free Net Working Capital to Revenue
33.55% 30.32% 34.09% 31.45% 29.88% 25.14% 28.16% 28.44% 26.50% 21.64% 24.04%
Debt-free Net Working Capital to Revenue
39.72% 39.82% 39.43% 40.75% 40.94% 39.01% 41.28% 40.73% 40.25% 39.39% 39.48%
Net Working Capital to Revenue
39.56% 39.67% 38.92% 40.48% 40.63% 38.59% 40.85% 40.30% 39.86% 39.04% 39.17%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.29 $1.53 $0.30 $0.57 $0.33 $0.42 $0.19 $0.29 $0.11 ($0.20) $0.05
Adjusted Weighted Average Basic Shares Outstanding
393M 393M 394M 395M 392M 392M 381M 375M 370M 372M 361M
Adjusted Diluted Earnings per Share
$0.29 $1.50 $0.30 $0.57 $0.33 $0.40 $0.19 $0.29 $0.11 ($0.20) $0.05
Adjusted Weighted Average Diluted Shares Outstanding
396M 397M 397M 397M 395M 396M 383M 376M 371M 375M 364M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
393.93M 394.00M 395.54M 393.71M 389.08M 380.82M 375.74M 371.36M 364.75M 360.40M 358.89M
Normalized Net Operating Profit after Tax (NOPAT)
127 113 119 238 145 167 93 142 64 64 27
Normalized NOPAT Margin
5.80% 4.81% 5.51% 10.75% 6.62% 7.26% 4.42% 6.48% 2.96% 2.83% 1.31%
Pre Tax Income Margin
7.14% 5.76% 7.66% 13.22% 7.94% 8.62% 5.75% 5.26% 3.35% 2.90% 1.71%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
6.87 5.78 6.33 13.59 8.76 8.88 6.00 5.73 4.32 3.41 2.23
NOPAT to Interest Expense
5.51 30.85 4.95 10.83 6.90 6.98 4.23 6.44 2.93 -5.13 1.22
EBIT Less CapEx to Interest Expense
3.65 2.48 3.46 9.86 4.86 3.96 2.18 1.95 -0.55 -1.18 -0.73
NOPAT Less CapEx to Interest Expense
2.29 27.55 2.08 7.10 3.00 2.06 0.41 2.67 -1.93 -9.72 -1.73
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
16.16% 8.02% 8.05% 8.50% 9.17% 17.01% 19.73% 40.29% 48.86% 125.83% 201.03%
Augmented Payout Ratio
16.16% 8.02% 8.05% 12.03% 20.11% 53.07% 72.45% 111.69% 135.88% 334.44% 511.34%

Financials Breakdown Chart

Key Financial Trends

Here is a concise, investor-focused look at NOV Inc. (NYSE: NOV) using the last four years of quarterly statements provided. The highlights below focus on notable trends in revenue, margins, cash flow, and balance-sheet changes, with a focus on the most meaningful 2025 results.

  • Q4 2025 revenue rose to $2.277B, up from $2.176B in Q3 2025.
  • Q4 2025 gross profit was $462M, delivering an estimated gross margin of about 20.3% (462M / 2.277B), higher than Q3’s roughly 18.9%.
  • Q4 2025 net cash from continuing operating activities was $573M, signaling solid cash generation from core operations.
  • Q4 2025 free cash flow was around $472M (roughly $573M operating cash flow minus $101M capex), indicating meaningful cash generation after investments.
  • Q4 2025 on-hand dividends per share: $0.08, reflecting ongoing capital return to shareholders.
  • Long-term debt declined modestly in 2025, from about $1.719B in Q1 2025 to about $1.692B by Q3 2025, suggesting gradual deleveraging.
  • Selling, General & Admin expenses remained in a tight band around $300–$305M in 2025, indicating a relatively stable cost structure.
  • Revenue hovered in a fairly narrow range around $2.1–$2.3B across 2022–2025, suggesting a stable top-line environment despite quarterly fluctuations.
  • Q4 2025 net income attributable to common shareholders was −$78M, with basic/diluted earnings per share of −$0.20, marking a quarterly loss for shareholders.
  • Q4 2025 income tax expense was unusually high at $147M, contributing to the quarter’s bottom-line loss despite positive revenue trends.
05/18/26 11:29 PM ETAI Generated. May Contain Errors.

NOV Financials - Frequently Asked Questions

According to the most recent income statement we have on file, NOV's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

NOV's net income appears to be on a downward trend, with a most recent value of $151 million in 2025, falling from -$767 million in 2015. The previous period was $635 million in 2024. See where experts think NOV is headed by visiting NOV's forecast page.

NOV's total operating income in 2025 was $494 million, based on the following breakdown:
  • Total Gross Profit: $1.77 billion
  • Total Operating Expenses: $1.27 billion

Over the last 10 years, NOV's total revenue changed from $14.76 billion in 2015 to $8.74 billion in 2025, a change of -40.7%.

NOV's total liabilities were at $4.97 billion at the end of 2025, a 0.7% increase from 2024, and a 47.7% decrease since 2015.

In the past 10 years, NOV's cash and equivalents has ranged from $816 million in 2023 to $2.08 billion in 2015, and is currently $1.55 billion as of their latest financial filing in 2025.

Over the last 10 years, NOV's book value per share changed from 43.60 in 2015 to 17.18 in 2025, a change of -60.6%.



Financial statements for NYSE:NOV last updated on 5/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners